MEDEX BALTIC, UAB - financials and debts

Company age: 19 y. 8 mo.

Update

MEDEX BALTIC - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 609,217 726,132 449,743 484,276 614,250 692,743 804,798 873,059
Profit before tax 5,226 60,684 51,017 12,300 6,614 40,742 107,448 91,966
Net profit 4,756 55,331 44,706 10,455 4,896 34,535 91,451 78,171
Equity 108,994 164,325 209,031 219,486 224,382 258,917 350,368 428,539
Liabilities 32,217 35,600 42,633 33,546 127,798 117,586 89,583 44,432
Non-current assets 34,557 26,533 37,268 34,937 97,871 83,189 62,996 41,606
Current assets 106,654 173,392 214,396 218,095 254,309 293,314 401,570 453,160
Total assets 141,211 199,925 251,664 253,032 352,180 376,503 464,566 494,766
Taxes paid
STI taxes - - - - - 78,418 102,356 117,505
Social insurance contributions - - - - - 13,092 17,174 19,513
Financial indicators
Revenue change y/y +20.0% +19.2% -38.1% +7.7% +26.8% +12.8% +16.2% +8.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 3.4% 27.7% 17.8% 4.1% 1.4% 9.2% 19.7% 15.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 4.4% 33.7% 21.4% 4.8% 2.2% 13.3% 26.1% 18.2%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.8% 7.6% 9.9% 2.2% 0.8% 5.0% 11.4% 9.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.9% 8.4% 11.3% 2.5% 1.1% 5.9% 13.4% 10.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.2 0.2 0.2 0.6 0.5 0.3 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 102,966 119,365 110,142 121,069 153,563 173,186 201,200 218,265

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

MEDEX BALTIC - Social security debts

From To Debt, €
2023-03-16 2023-03-21 642.37

MEDEX BALTIC - VMI tax arrears

From To Overdue, €
2025-02-20 2025-02-24 0.09
2025-01-30 2025-02-10 0.09
2024-12-30 2025-01-24 0.09
2024-12-19 2024-12-23 0.09

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
MEDEX BALTIC, UAB (code 300637605) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, revenue reached €873.1K, increasing 8.5% year on year and 26.0% over two years. Net profit was €78.2K, with a profit margin of 8.9%, below the 2024 high but still stronger than in 2023. The company’s profitability improved sharply from €34.5K in 2023 to €91.5K in 2024, before moderating in 2025. The balance sheet remained solid, with total assets of €494.8K, equity of €428.5K and liabilities of €44.4K. Equity represented 86.6% of assets, and debt-to-equity stood at 0.10, indicating a conservative leverage profile. Asset turnover was 1.76x, showing efficient use of assets in generating sales. Revenue per employee reached €218.3K and profit per employee €19.5K. Overall, the 2023-2025 trend points to steady revenue growth, healthy earnings and a strong capital structure.